Table 1.
Diseases associated with gut microbiome dysbiosis.
| Disease | Microbiome change | Functional effect | Ref. |
|---|---|---|---|
| Obesity | Firmicutes/Bacteroidetes ratio ↑ | Enhanced carbohydrate fermentation and nutrient absorption | [52] |
| Porphyromonas, Campylobacter, Bacteroides, Staphylococcus, Parabacteroides, Dialister, Ruminococcus ↑ | Associated with low microbial diversity, inflammation, and metabolic dysregulation | [53] | |
| Christensenellaceae, Methanobacteriales, Bifidobacteria, Akkermansia ↓ | Reduced probiotics linked to inflammation and metabolic dysfunction | [54] | |
| Type 2 Diabetes (T2D) |
Firmicutes ↓ Betaproteobacteria, Lactobacillus ↑ |
Reduced glucose tolerance, systemic inflammation, and metabolic dysregulation | [56] |
| F. prausnitzii, R. intestinalis ↓ | Loss of butyrate producers linked to reduced insulin sensitivity and impaired glucose regulation | [57] | |
| Bifidobacterium, Bacteroides, Akkermansia ↓ | Impaired gut barrier, immune dysfunction, and reduced insulin sensitivity | [58] | |
| Inflammatory Bowel Disease (IBD) | F. prausnitzii, Bifidobacterium, Firmicutes ↓ | Reduced butyrate production, impaired mucosal protection, and increased inflammation | [62] |
| Clostridium leptum group, Firmicutes ↓ | Reduced butyrate production and impaired mucosal immune regulation | [63] | |
| Bacteroides group, Bifidobacterium spp., Clostridium leptum group, Firmicutes ↓ Enterobacteria ↑ | Pro-inflammatory potential and epithelial adhesion | [64] |